Search

Your search keyword '"Morrissey, Brian"' showing total 84 results
Start Over Author "Morrissey, Brian" Search Limiters Peer Reviewed
84 results on '"Morrissey, Brian"'

1. Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial

Author

Files, D. Clark, Aggarwal, Neil, Albertson, Timothy, Auld, Sara, Beitler, Jeremy R., Berger, Paul, Burnham, Ellen L., Calfee, Carolyn S., Cobb, Nathan, Crippa, Alessio, Discacciati, Andrea, Eklund, Martin, Esserman, Laura, Friedman, Eliot, Gandotra, Sheetal, Khan, Kashif, Koff, Jonathan, Kumar, Santhi, Liu, Kathleen D., Martin, Thomas R., Matthay, Michael A., Meyer, Nuala J., Obermiller, Timothy, Robinson, Philip, Russell, Derek, Thomas, Karl, Wong, Se Fum, Wunderink, Richard G., Wurfel, Mark M., Yen, Albert, Youssef, Fady A., Darmanian, Anita, Dzierba, Amy L., Garcia, Ivan, Gosek, Katarzyna, Madahar, Purnema, Mittel, Aaron M., Muir, Justin, Rosen, Amanda, Schicchi, John, Serra, Alexis L., Wahab, Romina, Gibbs, Kevin W., Landreth, Leigha, LaRose, Mary, Parks, Lisa, Wynn, Adina, Ittner, Caroline A.G., Mangalmurti, Nilman S., Reilly, John P., Harris, Donna, Methukupally, Abhishek, Patel, Siddharth, Boerger, Lindsie, Kazianis, John, Higgins, Carrie, McKeehan, Jeff, Daniel, Brian, Fields, Scott, Hurst-Hopf, James, Jauregui, Alejandra, Brown Swigart, Lamorna, Blevins, Daniel, Nguyen, Catherine, Suarez, Alexis, Tanios, Maged A., Sarafian, Farjad, Shah, Usman, Adelman, Max, Creel-Bulos, Christina, Detelich, Joshua, Harris, Gavin, Nugent, Katherine, Spainhour, Christina, Yang, Philip, Haczku, Angela, Hardy, Erin, Harper, Richart, Morrissey, Brian, Sandrock, Christian, Budinger, G. R. Scott, Donnelly, Helen K., Singer, Benjamin D., Moskowitz, Ari, Coleman, Melissa, Levitt, Joseph, Lu, Ruixiao, Henderson, Paul, Asare, Adam, Dunn, Imogene, and Botello Barragan, Alejandro

Published
2023
Full Text
View/download PDF

2. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

Author

Einstein, Andrew J., Paez, Diana, Dondi, Maurizio, Better, Nathan, Cerci, Rodrigo, Dorbala, Sharmila, Karthikeyan, Ganesan, Pascual, Thomas N.B., Shaw, Leslee J., Villines, Todd C., Vitola, Joao V., Williams, Michelle C., Pynda, Yaroslav, Hinterleitner, Gerd, Lu, Yao, Morozova, Olga, Xu, Zhuoran, Hirschfeld, Cole B., Cohen, Yosef, Erinne, Ikenna, Malkovskiy, Eli, Randazzo, Michael, Sewanan, Lorenzo, Shetty, Mrinali, Choi, Andrew, Lopez-Mattei, Juan, Parwani, Purvi, Goda, Artan, Shirka, Ervina, Bouyoucef, Salah, Chelghoum, Lydia, Mansouri, Farouk, Medjahedi, Abdelkader, Naili, Qais, Ridouh, Mokhtar, Alasia, Diego, Alberghina, Lucia, Aramayo, Natalia, Buchara, Diego, Busso, Franco Gabriel, Bustos Rivadero, Jose Javier, Camilletti, Jorge, Campanelli, Hugo, Campisi, Roxana, Castro, Ricardo Belisario, Daicz, Mariana, del Riego, Horacio, Dragonetti, Laura, Echazarreta, Diego, Erriest, Juan, Faccio, Fernando, Facello, Adolfo, Gallegos, Hugo, Geronazzo, Ricardo, Glait, Horacio, Hasbani, Victor, Jäger, Victor, Lewkowicz, Julio Manuel, Lotti, Jose, Maciel, Neiva, Masoli, Osvaldo, Mastrovito, Edgardo, Medus, Maria, Merani, Maria Fernanda, Molteni, Susana, Montecinos, Marcos, Parisi, Gustavo, Sueldo, Claudio Pereyra, Perez de Arenaza, Diego, Quintana, Luis, Radzinschi, Alejandro, Redruello, Marcela, Rodríguez, Marina, Rojas, Horacio, Acuña, Arturo Romero, Schere, Daniel, Traverso, Sonia, Vazquez, Gustavo, Zeffiro, Susana, Sakanyan, Mari, Beuzeville, Scott, Boktor, Raef, Crowley, Michael, Downie, D'Arne, Dwivedi, Girish, Elison, Barry, Farouque, Omar, Jasper, Kim, Joshi, Subodh, Lee, Joseph, Lee, Kenneth, Lui, Elaine, Mcconachie, Peter, Meaker, Joanne, Nandurkar, Dee, Neill, Johanne, O'Rourke, Edward, O'Sullivan, Patricia, Pandos, George, Premaratne, Manuja, Prior, David, Rutherford, Natalie, Saunders, Connor, Taubman, Kim, Tauro, Andrew, Taylor, Andrew, Theuerle, James, Thomas, Paul, Tow, Jonathan, Upton, Anthony, Vamadevan, Shankar, Wayne, Victor, Wegner, Eva Alina, Wong, David, Younger, John, Beitzke, Dietrich, Feuchtner, Gudrun, Sommer, Oliver, Weiss, Konrad, Maroz-Vadalazhskaya, Natallia, Tserakhau, Uladzimir, Homans, Filip, Van De Heyning, Caroline M., Araujo, Raúl, Soldat-Stankovic, Valentina, Stankovic, Sinisa, Almeida, Augusto, Anselmi, Carlos, Azevedo, Guilherme S.A., Bittencourt, Marcio Sommer, Pianta, Diego Bromfman, Cabeda, Estevan, Carreira, Lara, Coelho, Igor, de Amorim Fernandes, Fernando, de Lorenzo, Andrea, Delgado, Roberta, Erthal, Fernanda, Fernandes, Fabio, Fernandes, Juliano, Ferreira de Souza, Thiago, Foppa, Murilo, Matos Alves, Wilson Furlan, Gontijo, Cibele, Gottlieb, Ilan, Grossman, Gabriel, Albernaz Siqueira, Maria Helena, Nomura, Cesar Higa, Koga, Katia Hiromoto, Lima, Ronaldo, Lopes, Rafael, Marçal Filho, Hugo Humberto, Masiero, Paulo, Mastrocola, Luiz, Menezes de Siqueira, Maria Eduarda, Mesquita, Claudio, Naves, Danilo, Penna, Filipe, Pinto, Ibraim, Rocha, Thércio, Rocha, Juliana Leal, Rodrigues, Alfredo, Salioni, Leila, Sanches, Adelina, Santos, Marcelo, Da Silva, Leonardo Sara, Schvartzman, Paulo, Matushita, Cristina Sebastião, Senra, Tiago, Silva, Marcelo, Soares, Carlos Eduardo, Spiro, Bernardo, Suaide Silva, Carlos Eduardo, Torres, Rafael, Monte, Guilherme Urpia, Vilela, Andrea, Villa, Alexandre Volney, Vitola, Joao, Voss, Themissa, Waltrick, Roberto, Zapparoli, Marcello, Naseer, Hamid, Garcheva-Tsacheva, Marina, Ouattara, Tiémégna Florence, Thou, Sarameth, Varoeun, Soley, Abikhzer, Gad, Beanlands, Rob, Chetrit, Michael, Dabreo, Dominique, Dennie, Carole, Friedrich, Matthias, Hafez, Mohmmed Nassoh, Hanneman, Kate, Miller, Robert, Oikonomou, Anastasia, Roifman, Idan, Small, Gary, Tandon, Vikas, Trivedi, Adwait, White, James, Zukotynski, Katherine, Alay, Rita, Concha, Carmen, Massardo, Teresa, Abad, Pedro, Anzola, Kelly, Arturo, Harold, Benitez, Luis, Cadena, Alberto, Zamudio, Carlos Caicedo, Calderón, Antonio, Gutierrez Villamil, Claudia T., Jaimes, Claudia, Londono, Juan L., Lopez, Nelson, Merlano-Gaitan, Sonia, Murgieitio-Cabrera, Ramon, Valencia, Manuel, Vergel, Damiana, Santamaria, Alejandro Zuluaga, Solis, Felix, Batinic, Tonci, Franceschi, Maja, Paar, Maja Hrabak, Prpic, Marina, Felipe Batista, Cuba: Juan, Cabrera, Lazaro Omar, Peix, Amalia, Peña, Yamilé, Rochela Vázquez, Luis Manuel, Ntalas, Ioannis, Kaminek, Milan, Kincl, Vladimir, Lang, Otto, Abdulla, Jawdat, Bøttcher, Morten, Busk, Martin, Geisler, Uka, Gormsen, Lars C., Hansson, Nicolaj, Hess, Søren, Hove, Jens, Jensen, Lars Thorbjoern, Jensen, Magnus T., Kragholm, Kristian Hay, Nørgaard, Bjarne L., Øvrehus, Kristian, Rasmussen, Jan, Rønnow Sand, Niels Peter, Sondergaard, Hanne, Zaremba, Tomas, Speckter, Herwin, Amores, Nelson, Velez, Mayra Sanchez, Alrahman, Taghreed Abd, Elsamad, Sherif Abd, Abdelfattah, Alia, Allam, Adel, Elkaffas, Sameh, Hassan, Mona, Hussein, Elshaymaa, Ibrahim, Ahmed, Kandeel, Ahmed, Ali, Mohamed Mandour, Shaaban, Mahmoud, Flores, Camila, Gómez Leiva, Verónica Vanesa, Liiver, Anita, Larikka, Martti, Uusitalo, Valtteri, Agostini, Denis, Berger, Clothilde, Dietz, Matthieu, Hyafil, Fabien, Ohana, Mickaël, Prigent, Kevin, Regaieg, Hamza, Sarda-Mantel, Laure, H-Ici, Darach O., Ayetey, Harold, Angelidis, George, Fragkaki, Christina, Fragkiadaki, Chrysoula, Georgoulias, Panagiotis, Koutelou, Maria, Kyrozi, Elena, Lama, Niki, Prassopoulos, Vassilis, Spartalis, Michael, Zaglavara, Theodora, Gonzalez, Carla, Gutierrez, Goleat, Maldonado, Alejandro, Martinez, Yassine, Kovács, Attila, Szilveszter, Bálint, Banthia, Nilesh, Bhat, Vivek, Bhatia, Mona, Choudhury, Partha, Chowdekar, Vijay Sai, Christopher, Johann, Garg, Tushar, Goyal, Naresh Kumar, Gupta, Ripen Kumar, Gupta, Abhishek, Hephzibah, Julie, Jain, Shashank, Krupa, Jesu, Kumar, Parveen, Kumar, Sukriti, Lalchandani, Arati, Mishra, Animesh, Mishra, Vivaswan Dutt, Mohan, Parul, Ozair, Ahmad, Pandey, Shivani, Parameswaran, Ramanathapuram, Patel, Chetan, Patel, Tapan, Patel, Shivani, Vimala, Leena Robinson, Kumar Sarangi, Dr Pradosh, Sengupta, Shantanu, Sethi, Arvind, Sharma, Amit, Sharma, Awadhesh Kumar, Sharma, Punit, Shrigiriwar, Apurva, Singh, Santosh, Singh, Harpreet, Sood, Ashwani, Verma, Atul, Vyas, Ajay, Soeriadi, Erwin Affandi, Bun, Edison, Hutomo, Febby, Syawaluddin, Hilman, Yudistiro, Ryan, Albadr, Amjed, Assadi, Majid, Emami, Farshad, Emami-Ardekani, Alireza, Farzanehfar, Saeed, Jafari, Ramezan, Manafi-Farid, Reyhaneh, Tajik, Maryam, Arnson, Yoav, Fuchs, Shmuel, Goldkorn, Ronen, Kennedy, John, Leitman, Marina, Shalev, Aryeh, Acampa, Wanda, Albano, Domenico, Alongi, Pierpaolo, Arnone, Gaspare, Assante, Roberta, Baritussio, Anna, Bauckneht, Matteo, Bianco, Francesco, Bonfiglioli, Rachele, Bovenzi, Francesco, Bruno, Isabella, Bruno, Andrea, Busnardo, Elena, Califaretti, Elena, Casoni, Roberta, Censullo, Vittorio, Chierichetti, Franca, Chiocchi, Marcello, Cittanti, Corrado, Clemente, Alberto, Cuocolo, Alberto, De Rimini, Maria Luisa, De Vincentis, Giuseppe, Della Tommasina, Veronica, Dellegrottaglie, Santo, Erba, Paola Anna, Evangelista, Laura, Faggi, Lara, Faragasso, Evelina, Florimonte, Luigia, Frantellizzi, Viviana, Gatti, Marco, Gaudiano, Angela, Gelardi, Fabrizia, Gerali, Alberto, Gimelli, Alessia, Guglielmo, Marco, Leccisotti, Lucia, Liga, Riccardo, Liguori, Carlo, Longo, Giampiero, Maffione, Margherita, Marcassa, Claudio, Matassa, Giovanni, Mele, Donato, Milan, Elisa, Mircoli, Luca, Paccagnella, Andrea, Pacella, Sara, Padovano, Federica, Pellegrini, Dario, Pergola, Valeria, Pugliese, Luca, Quartuccio, Natale, Rampin, Lucia, Ricci, Fabrizio, Rubini, Giuseppe, Russo, Vincenzo, Sambuceti, Gianmario, Scatteia, Alessandra, Sciagrà, Roberto, Spidalieri, Gianluca, Stefanelli, Antonella, Tedeschi, Carlo, Ventroni, Guido, Baugh, Dainia, Madu, Ernest, Aikawa, Tadao, Asano, Hiroshi, Fujimoto, Shinichiro, Fujise, Koichiro, Fukushima, Yoshimitsu, Fukuyama, Kae, Ichikawa, Yasutaka, Ideguchi, Reiko, Iguchi, Nobuo, Imai, Masamichi, Ishimura, Hayato, Isobe, Satoshi, Ito, Kimiteru, Izawa, Yu, Kadokami, Toshiaki, Kasai, Tokuo, Kato, Takao, Kawamoto, Takashi, Kiryu, Shigeru, Kumita, Shinichiro, Manabe, Osamu, Maruno, Hirotaka, Matsumoto, Naoya, Miyagawa, Masao, Moroi, Masao, Nagamachi, Shigeki, Nakajima, Kenichi, Nakazato, Ryo, Nanasato, Mamoru, Naya, Masanao, Norikane, Takashi, Ohta, Yasutoshi, Otomi, Yoichi, Otsuka, Hideki, Oyama-Manabe, Noriko, Saito, Masaki, Sarai, Masayoshi, Sato, Junichi, Sato, Daisuke, Shiraishi, Shinya, Takanami, Kentaro, Takehana, Kazuya, Taniguchi, Yasuyo, Teragawa, Hiroki, Tomizawa, Nobuo, Umeji, Kyoko, Wakabayashi, Yasushi, Yamada, Shinichiro, Yamazaki, Shinya, Yoneyama, Tatsuya, Rawashdeh, Mohammad, Dautov, Tairkhan, Makhdomi, Khalid, Abass, Mostafa, Garashi, Masoud, Siraj, Qaisar, Kalnina, Marika, Haidar, Mohamad, Komiagiene, Renata, Kviecinskiene, Giedre, Vajauskas, Donatas, Karim, Noor Khairiah A., Doucoure, Mady, Reichmuth, Luise, Samuel, Anthony, Dieng, Mohamed Lemine, Naojee, Ambedhkar Shantaram, Hernandez, Estrella Aguilera, Alducin Tellez, Cesar Rene, Alexánderson-Rosas, Erick, Barragan, Erika, Cabada, Manuel, Calderón, Daniel, Carvajal-Juarez, Isabel, Esparza, José, Gama-Moreno, Manlio Gerardo, Quinto, Virginia Garcia, Gonzalez, Nelsy Coromoto, Herrera-Zarza, Mary Carmen, Meave, Aloha, Medina Verdugo, Jesus Gregorio, Melendez, Gabriela, Morales Murguia, Rafael Humberto, Navarro Quiroz, Carlos Salvador, Ornelas, Mario, Preciado-Anaya, Andres, Preciado-Gutiérrez, Oscar Ulises, Puente, Adriana, Salazar, Aristóteles Ramírez, Rosales Uvera, Sandra Graciela, Rosales-Uvera, Sandra, Serna Macias, Jose Antonio, Sierra-Galan, Lilia, Sierra-Galan, Lilia M., Tirado Alderete, Juan Carlos, Vallejo, Enrique, Faraggi, Marc, Sereegotov, Erdenechimeg, Ben Rais, Nouzha, Alaoui, Nadia Ismaili, Kyiphyu, Thiri, Oo, Su Thet, Win, Soe Myat, Zar, Htin, Ghimire, Ram, Neupane, Madhu, Glaudemans, Andor, Slart, Riemer, Verschure, Derk, Allen, Berry, Edmond, John, Mckenzie, Clare, Tie, Stuart, Van Pelt, Niels, Worthington, Kirsten, Young, Calum, Soli, Idrissa Adamou, Kana, Shehu, Onubogu, Uchenna, Sani, Mahmoud, Bråten, Anders Tjellaug, Jørgensen, Arve, Vassbotn, Hanne-Elin, Al Dhuhli, Humoud, Jawa, Zabah, Tag, Naima, Fatima, Shazia, Imran, Muhammad Babar, Younis, Muhammad Numair, Saadullah, Mohammad, Malo, Yariela Herrera, Lenturut-Katal, Dora, Castillo, Manuel, Ortellado, José, Akhter, Afroza, Cader, F. Aaysha, Hussain, Raihan, Khan, Saidur Rahman, Mandal, Tapati, Nasreen, Faria, An, Yunqiang, Cao, Dianbo, Gong, Lianggeng, Hou, Yang, Jia, Chongfu, Li, Tao, Li, Caiying, Liu, Hui, Liu, Wenya, Liu, Jinkang, Lu, Bin, Ng, Ming-Yen, Shi, Heshui, Tang, Chunxiang, Wang, Ximing, Wang, Zhaoqian, Wang, Yining, Wu, Jiang, Yi, Yan, Yuan, Li, Zhang, Tong, Zhang, Longjiang, Chavez, Edith, Cruz, Carlos, Llontop, Christian, Morales, Rosanna, Abrihan, Paz, Bustos-Barroso, Asela, Duldulao-Ogbac, Michele, Eduarte, Christopher, Obaldo, Jerry, Quinon, Alvin, San Juan, Belinda, San Juan, Carlo Joe, Sauler-Gomez, Marie Rhiamar, Uy, Mila, Kostkiewicz, Magdalena, Kunikowska, Jolanta, Teresinska, Anna, Urbanik, Tomasz, Bettencourt, Nuno, Fontes-Carvalho, Ricardo, Gavina, Cristina, Gonçalves, Lino, Macedo, Filipe, Moreno, Nuno, Sousa, Carla, Timoteo, Ana Teresa, Vidigal, Maria João, Al Heidous, Mahmoud, Ramanathan, Subramaniyan, Arnous, Samer, Aytani, Said, Byrne, Angela, Gleeson, Tadhg, Kerins, David, O'Brien, Julie, Bang, Ji-In, Bom, Henry, Cheon, Miju, Cheon, Gi Jeong, Cho, Sang-Geon, Hong, Chae Moon, Jeong, Yong Hyu, Kang, Won Jun, Kang, Yeon-Koo, Kim, Ji-Young, Oh, So Won, So, Young, Song, Ho-Chun, Won, Kyoung Sook, Yoo, Soo Woong, Mitevska, Irena, Vavlukis, Marija, Salobir, Barbara Gužic, Štalc, Monika, Benedek, Theodora, Pop, Marian, Stan, Claudiu, Ansheles, Alexey, Dariy, Olga, Gagarina, Nina, Itskovich, Irina, Karalkin, Anatoliy, Kokov, Alexander, Marina, Gulya, Migunova, Ekaterina, Pospelov, Viktor, Ryzhkova, Daria, Sayfullina, Guzaliya, Sergienko, Vladimir, Shurupova, Irina, Sinitsyn, Valentin, Vakhromeeva, Margarita, Valiullina, Nailia, Zavadovsky, Konstantin, Zhuravlev, Kirill, Abazid, Rami, Al Garni, Turki, Alasnag, Mirvat, Aljizeeri, Ahmed, Amer, Hamid, Amro, Ahmad, Hamdy, Hesham, Smettei, Osama, Saranovic, Dragana Sobic, Vlajkovic, Marina, Keng, Felix, See, Jason, Berecova, Zuzana, Mistinova, Jana Polakova, Evbuomwan, Osayande, Govender, Nerisha, Hack, Jonathan, Hadebe, Bawinile, Hlongwa, Khanyisile, Kaplan, Mitchell, Lakhi, Hoosen, Milos, Katarina, Modiselle, Moshe, More, Stuart, Muambadzi, Ntanganedzeni, Scholtz, Leonie, Barreiro-Perez, Manuel, Blanco, Isabel, Broncano, Jordi, Camarero, Alicia, Casáns-Tormo, Irene, De Haro, Javier, Flotats, Albert, García, Elia, Mendiguchia, Ceferino Gutierrez, Jimenez-Heffernan, Amelia, Leta, Ruben, Diaz, Javier Lopez, Vega, Luis Lumbreras, Manovel-Sánchez, Ana, Monzonis, Amparo Martinez, Patrut, Bianca, Pubul, Virginia, Perez, Ricardo Ruano, Zeidan, Nahla, Nanayakkara, Damayanthi, Suliman, Ahmed, Engblom, Henrik, Murtadha, Mustafa, Ostenfeld, Ellen, Simonsson, Magnus, Alkadhi, Hatem, Buechel, Ronny Ralf, Burger, Peter, Gräni, Christoph, Kamani, Christel, Kawel-Böhm, Nadine, Klaeser, Bernd, Manka, Robert, Prior, John, Kaewchur, Tawika, Khiewvan, Benjapa, Kositwattanarerk, Arpakorn, Namwongprom, Sirianong, Thientunyakit, Tanyaluck, Sayman, Haluk Burcak, Yüksel, Mahmut, Sebikali, Mugisha Julius, Okello, Emmy, Korol, Pavlo, Noverko, Iryna, Satyr, Maryna, Ahmad, Tahir, Alfakih, Khaled, Andrade, Ivo, Buckingham, Susan, Bularga, Anda, Carpenter, John-Paul, Cole, Graham, Cusack, David, David, Sarojini, Davis, Patrick, Fairbairn, Timothy, Ghosh, Arjun, Ramkumar, Prasad Guntur, Hamilton, Mark, Haque, Faisal, Hudson, Benjamin, Johnstone, Annette, Karthikeyan, V.J., Kay, Mike, Khan, Mohammad Ali, Kitt, Jamie, Low, Chen Sheng, Mcalindon, Elisa, Mccreavy, David, Morrissey, Brian, Motwani, Manish, Na, Dilip, Nicol, Edward, Patel, Dilip, Rodrigues, Jonathan, Rofe, Chris, Schofield, Rebecca, Semple, Thomas, Sheikh, Azeem, Sinha, Apurva, Subedi, Deepak, Topping, William, Tweed, Katherine, Underwood, Stephen Richard, Weir-Mccall, Jonathan, Zuhairy, Hamed, Abbasi, Taimur, Abohashem, Shady, Abramson, Sandra, Al-Mallah, Mouaz, Kumar, Mohan Ashok, Balmer-Swain, Mallory, Berman, Daniel, Bernheim, Adam, Bhatti, Sabha, Biederman, Robert, Bieging, Erik, Bingham, Scott, Bloom, Stephen, Blue, Sean, Borges, Andressa, Branch, Kelley, Bravo, Paco, Buddhe, Sujatha, Budoff, Matthew, Bullock-Palmer, Renée, Cahill, Michael, Candela, Candace, Cao, Jane, Chatterjee, Saurav, Chatzizisis, Yiannis, Chaudhuri, Nita Ray, Cheezum, Michael, Chelliah, Anjali, Chen, Tiffany, Chen, Marcus, Chen, Lu, Chokshi, Aalap, Chung, Jina, Danciu, Sorin, DeSisto, William, Dilorenzo, Michael, Doukky, Rami, Duvall, William, Ferencik, Maros, Foster, Cameron, Fuisz, Anthon, Gannon, Michael, German, David, Gerson, Myron, Geske, Jeffrey, Hage, Fadi, Haider, Agha, Haider, Sofia, Hamirani, Yasmin, Hassen, Karen, Hendel, Robert, Henkel, Jacqueline, Horgan, Stephen, Hyun, Mark, Janardhanan, Rajesh, Jerome, Scott, Kalra, Dinesh, Kassop, David, Kinkhabwala, Mona, Kinzfogl, George, Koch, Bernard, Koweek, Lynne, Krepp, Joseph, Kwon, Younghoon, Layer, Jay, Lesser, John, Leung, Steve, Lisske, Bernadette, Magurany, Kathleen, Markowitz, Jeremy, Mccullough, Brenda, Moalemi, Azita, Moffitt, Chanan, Montanez, Juan, Moore, Warren, Morayati, Shamil, Mossa-Basha, Mahmud, Mrsic, Zorana, Murthy, Venkatesh, Nagpal, Prashant, Nelson, Katarina, Nijjar, Prabhjot, O’Quinn, Rupal, Passen, Edward, Patel, Toral, Patil, Pravin, Pursnani, Amit, Quachang, Nancy, Rabbat, Mark, Ranjan, Pragya, Lozano, Patricia Rodriguez, Schemmer, Mary, Seifried, Rebecca, Shah, Nishant, Shah, Amee, Shanbhag, Sujata, Sharma, Gaurav, Skotnicki, Robert, Sobczak, Michael, Soman, Prem, Sorrell, Vincent, Srichai, Monvadi, Streeter, Jim, Strickland, Leah, Suliman, Suliman, Tebyanian, Naghmeh, Thomas, Dustin, Thompson, Randall, Uretsky, Seth, Vallurupalli, Srikanth, Vandyck-Acquah, Marian, Verma, Vikas, Villines, Todd, Weinstein, Joseph, Wolinsky, David, Zareba, Karolina, Zgaljardic, Michael, Beretta, Mario, Ferrando, Rodolfo, Kapitan, Miguel, Mut, Fernando, Djuraev, Omoa, Rozikhodjaeva, Gulnora, Vera, Luisa, Duc, Binh Duong, Nguyen, Xuan Canh, Hiep Nguyen, Phuoc Minh, Hirschfeld, Cole, Choi, Andrew D., Ansheles, Alexey A., Kudo, Takashi, Bucciarelli-Ducci, Chiara, Nørgaard, Bjarne Linde, Maurovich-Horvat, Pál, Louw, Lizette, Allam, Adel H., and Narula, Jagat

Published
2022
Full Text
View/download PDF

3. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Author

Gibson, Ronald L., Jr., Rowe, Steven M., Lechtzin, Noah, Ahrens, Richard C., McCoy, Karen S., Aitken, Moira, Donaldson, Scott H., McBennett, Kimberly Ann, Pilewski, Joseph M., Billings, Joanne, Milla, Carlos, Rubenstein, Ronald, Rosenbluth, Daniel Brian, Linnemann, Rachel, Powers, Michael R., Fortner, Christopher, Frederick, Carla Anne, Liou, Theodore G., Black, Philip, Wang, Janice, Colombo, John L., Berdella, Maria, Indihar, Maria Veronica, Brown, Cynthia D., Anstead, Michael, Bilodeau, Lara, Sicilian, Leonard, Jain, Manu, Tolle, James Jerome, Moffett, Kathryn, Nasr, Samya, Taylor-Cousar, Jennifer, Barto, Tara Lynn, Antos, Nicholas, Rogers, John S., Quick, Bryon, Thompson, Henry R., Sawicki, Gregory, Barnett, Bruce, Zanni, Robert L., Smith, Thomas C., Schultz, Karen D., Keating, Claire, Flume, Patrick, Omlor, Gregory J., Ashare, Alix, Voter, Karen, Mehdi, Nighat, Ortiz, Maria Gabriela Tupayachi, Gardner, Tonia E., Boas, Steven R., Messore, Barbara, Zemanick, Edith, Jain, Raksha, McCarthy, Michael, Kissner, Dana G., Patel, Kapilkumar, McNamara, John, Philley, Julie, Berlinski, Ariel, Calimano, Francisco J., Chin, Terry, Conrad, Douglas, Daines, Cori, Raissy, Hengameh H., Keens, Thomas G., Lascano, Jorge E., McWilliams, Bennie, Morrissey, Brian, Reyes, Santiago, Chittivelu, Subramanyam, Hussain, Sabiha, Stone, Arvey, Wallace, James, Klingsberg, Ross, Biller, Julie A., Bui, Stephanie, Sommerburg, Olaf, Bignamini, Elisabetta, Collura, Mirella, Biner, Reta Fischer, Moller, Alexander, Salvatore, Donatello, Belleguic, Chantal, Bentur, Lea, Efrati, Ori, Kerem, Eitan, Prais, Dario, Gallego, Esther Quintana, Barry, Peter, Livnat-Levanon, Galit, Asensi, Jose Ramon Villa, Armstrong, David Stuart, de la Cruz, Oscar Asensio, Gilchrist, Francis, Tullis, Diana Elizabeth, Quon, Bradley, Lands, Larry C., Morrison, Nancy, Lavoie, Annick, Linnane, Barry, Elidemir, Okan, Ringshausen, Felix, Kappler, Matthias, Hebestreit, Helge, Mainz, Jochen, Kiefer, Alexander, Koerner-Rettberg, Cordula, Staab, Doris, Gleiber, Wolfgang, Pressler, Tacjana, Stehling, Florian, Hector, Andreas, Sutharsan, Sivagurunathan, Naehrlich, Lutz, Fischer, Rainald, Downey, Damian, Davies, Jane Carolyn, Ketchell, Robert Ian, Carroll, Mary Patricia, Doe, Simon, MacGregor, Gordon, Nash, Edward Fairbairn, Withers, Nicholas, Peckham, Daniel Gavin, Ledson, Martin James, Kansra, Sonal, Lee, Timothy William Rayner, Delaisi, Bertrand, Rault, Gilles, Le Bihan, Jean, Hubert, Dominique, Fajac, Isabelle, Sermet-Gaudelus, Isabelle, Bakker, Marleen, Arets, Bert, De Boeck, Christiane, Chiron, Raphael, Reix, Philippe, Mainguy, Catherine, van Braeckel, Eva, Malfroot, Anne, Durieu, Isabelle, Dufeu, Nadine Desmazes, Prevotat, Anne, van der Meer, Renske, Merkus, Petrus, Weersink, E.J.M., Gomez-Aguero, Isabel Barrio, Gartner, Silvia, Jover, Amparo Sole, Fernandez, Antonio Alvarez, Cox, Desmond William, McKone, Edward F., Plant, Barry James, Selvadurai, Hiranjan, Bowler, Simon David, Wainwright, Claire Elizabeth, Smith, Daniel, Middleton, Peter Gordon, Wilson, John William, Volpi, Sonia, Colombo, Carla, Fabrizzi, Benedetta, Lucidi, Vincenzina, Cresta, Federico, Cucchiara, Salvatore, Eber, Ernst, Ellemunter, Helmut, Huttegger, Isidor, Hjelte, Lena, Krantz, Christina, Gilljam, Marita, Flume, Patrick A, Downey, Damian G, Brown, Cynthia, De Boeck, Kris, Sawicki, Gregory S, Chang, Philip, Paz-Diaz, Hildegarde, Rubin, Jaime L, Yang, Yoojung, Hu, Xingdi, Pasta, David J, Millar, Stefanie J, Campbell, Daniel, Wang, Xin, Ahluwalia, Neil, Owen, Caroline A, and Wainwright, Claire E

Published
2021
Full Text
View/download PDF

4. An open-source perceptual crossing device for investigating brain dynamics during human interaction.

Author

Estelle, Stephen, Uhlig, Kenzo, Zapata-Fonseca, Leonardo, Lerique, Sébastien, Morrissey, Brian, Sato, Rai, and Froese, Tom

Subjects
SOCIAL interaction, CIRCULAR motion, VIRTUAL reality, SCIENTIFIC community, USER experience
Abstract

The Perceptual Crossing Device (PCD) introduced in this report is an updated tool designed to facilitate the exploration of brain activity during human interaction with seamless real time integration with EEG equipment. It incorporates haptic and auditory feedback mechanisms, enabling interactions between two users within a virtual environment. Through a unique circular motion interface that enables intuitive virtual interactions, users can experience the presence of their counterpart via tactile or auditory cues. This paper highlights the key characteristics of the PCD, aiming to validate its efficacy in augmenting the understanding of human interactions. Furthermore, by offering an accessible and intuitive interface, the PCD stands to foster greater community engagement in the realm of embodied cognitive science and human interaction studies. Through this device, we anticipate a deeper comprehension of the complex neural dynamics underlying human interaction, thereby contributing a valuable resource to both the scientific community and the broader public. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension

Author

Hoedt-Miller Marloes, Morris Kenneth G, Harral Julie, Sato Koichi, Fouty Brian W, Morrissey Brian, Fagan Karen A, Vidmar Shanda, McMurtry Ivan F, and Rodman David M

Subjects
hypoxia, mice, nitric oxide (NO), nitric oxide synthase (NOS), pulmonary hypertension, Diseases of the respiratory system, RC705-779
Abstract

Abstract Background The importance of nitric oxide (NO) in hypoxic pulmonary hypertension has been demonstrated using nitric oxide synthase (NOS) knockout mice. In that model NO from endothelial NOS (eNOS) plays a central role in modulating pulmonary vascular tone and attenuating hypoxic pulmonary hypertension. However, the normal regulation of NOS expression in mice following hypoxia is uncertain. Because genetically engineered mice are often utilized in studies of NO, we conducted the present study to determine how hypoxia alters NOS expression in wild-type mice. Method Mice were exposed to sea level, ambient conditions (5280 feet) or severe altitude (17,000 feet) for 6 weeks from birth, and hemodynamics and lung NOS expression were assessed. Results Hypoxic mice developed severe pulmonary hypertension (right ventricular systolic pressure [RVsP] 60 mmHg) as compared with normoxic mice (27 mmHg). Using quantitative reverse-transcription PCR, it was found that expressions of eNOS and inducible NOS (iNOS) increased 1.5-fold and 3.5-fold, respectively, in the lung. In addition, the level of lung eNOS protein was increased, neuronal NOS (nNOS) protein was unchanged, and iNOS was below the limit of detection. Immunohistochemistry demonstrated no change in lung iNOS or nNOS staining in either central or peripheral areas, but suggested increased eNOS in the periphery following hypoxia. Conclusion In mice, hypoxia is associated with increases in lung eNOS, possibly in iNOS, but not in nNOS; this suggests that the pattern of lung NOS expression following hypoxia must be considered in studies using genetically engineered mice.

Published
2001
Full Text
View/download PDF

9. α-Tocopherol Pharmacokinetics in Adults with Cystic Fibrosis: Benefits of Supplemental Vitamin C Administration.

Author

Traber, Maret G., Leonard, Scott W., Vasu, Vihas T., Morrissey, Brian M., Lei, Huangshu, Atkinson, Jeffrey, and Cross, Carroll E.

Abstract

Background: Numerous abnormalities in cystic fibrosis (CF) could influence tocopherol absorption, transportation, storage, metabolism and excretion. We hypothesized that the oxidative distress due to inflammation in CF increases vitamin E utilization, which could be positively influenced by supplemental vitamin C administration. Methods: Immediately before and after receiving vitamin C (500 mg) twice daily for 3.5 weeks, adult CF patients (n = 6) with moderately advanced respiratory tract (RT) disease consumed a standardized breakfast with 30% fat and a capsule containing 50 mg each hexadeuterium (d6)-α- and dideuterium (d2)-γ-tocopheryl acetates. Blood samples were taken frequently up to 72 h; plasma tocopherol pharmacokinetics were determined. During both trials, d6-α- and d2-γ-tocopherols were similarly absorbed and reached similar maximal plasma concentrations ~18–20 h. As predicted, during vitamin C supplementation, the rates of plasma d6-α-tocopherol decline were significantly slower. Conclusions: The vitamin C-induced decrease in the plasma disappearance rate of α-tocopherol suggests that vitamin C recycled α-tocopherol, thereby augmenting its concentrations. We conclude that some attention should be paid to plasma ascorbic acid concentrations in CF patients, particularly to those individuals with more advanced RT inflammatory disease and including those with severe exacerbations. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

10. The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.

Author

Albertson, Timothy E., Chenoweth, James A., Lewis, Justin C., Pugashetti, Janelle V., Sandrock, Christian E., and Morrissey, Brian M.

Subjects
CARDIOTONIC agents, VASOCONSTRICTORS, ANGIOTENSIN II, VASOPRESSIN, SEPTIC shock, METHYLENE blue
Abstract

Septic and vasoplegic shock are common types of vasodilatory shock (VS) with high mortality. After fluid resuscitation and the use of catecholamine-mediated vasopressors (CMV), vasopressin, angiotensin II, methylene blue (MB), and hydroxocobalamin can be added to maintain blood pressure. VS treatment utilizes a phased approach with secondary vasopressors added to vasopressor agents to maintain an acceptable mean arterial pressure (MAP). This review covers additional vasopressors and adjunctive therapies used when fluid and catecholamine-mediated vasopressors fail to maintain target MAP. Evidence supporting additional vasopressor agents in catecholamine-resistant VS is limited to case reports, series, and a few randomized control trials (RCTs) to guide recommendations. Vasopressin is the most common agent added next when MAPs are not adequately supported with CMV. VS patients failing fluids and vasopressors with cardiomyopathy may have cardiotonic agents such as dobutamine or milrinone added before or after vasopressin. Angiotensin II, another class of vasopressor, is used in VS to maintain adequate MAP. MB and/or hydroxocobalamin, vitamin C, thiamine, and corticosteroids are adjunctive therapies used in refractory VS. More RCTs are needed to confirm the utility of these drugs, at what doses, which combinations and in what order they should be given. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

12. Speech and taxes: balancing freedom of conscience and government speech after Johanns v. Livestock Marketing Association.

Author

Morrissey, Brian P. Jr.

Subjects
Commercial speech doctrine -- Laws, regulations and rules, Tax collection -- Laws, regulations and rules, Government information -- Laws, regulations and rules, Johanns v. Livestock Marketing Ass'n (125 S. Ct. 2055 (2005)), Government regulation, United States Constitution (U.S. Const. amend. 1), Beef Promotion and Research Act of 1985
Published
2006

18. Construction law.

Author

Morrissey, Brian J. and Toler, Timothy N.

Subjects
Building law -- Surveys
Published
1999

22. Construction law.

Author

Morrissey, Brian J.

Subjects
Construction law -- Surveys
Published
1996

23. Construction law.

Author

Morrissey, Brian J.

Subjects
Construction law -- Surveys
Published
1995

24. Construction law.

Author

Morrissey, Brian J.

Subjects
Construction law -- Surveys
Published
1994

25. Construction law.

Author

Morrissey, Brian J. and Wallace, Matthew W.

Subjects
Construction industry -- Surveys, Contracts -- Surveys, Mechanics' liens -- Surveys
Published
1992

26. Construction law.

Author

Morrissey, Brian J. and Wallace, Matthew W.

Subjects
Construction law -- Surveys
Published
1991

27. Multiplexed measurement of candidate blood protein biomarkers of heart failure.

Author

Tonry, Claire, McDonald, Ken, Ledwidge, Mark, Hernandez, Belinda, Glezeva, Nadezhda, Rooney, Cathy, Morrissey, Brian, Pennington, Stephen R., Baugh, John A., and Watson, Chris J.

Subjects
HEART failure, BLOOD proteins, BIOMARKERS
Abstract

Aims: There is a critical need for better biomarkers so that heart failure can be diagnosed at an earlier stage and with greater accuracy. The purpose of this study was to design a robust mass spectrometry (MS)‐based assay for the simultaneous measurement of a panel of 35 candidate protein biomarkers of heart failure, in blood. The overall aim was to evaluate the potential clinical utility of this biomarker panel for prediction of heart failure in a cohort of 500 patients. Methods and results: Multiple reaction monitoring (MRM) MS assays were designed with Skyline and Spectrum Mill PeptideSelector software and developed using nanoflow reverse phase C18 chromatographic Chip Cube‐based separation, coupled to a 6460 triple quadrupole mass spectrometer. Optimized MRM assays were applied, in a sample‐blinded manner, to serum samples from a cohort of 500 patients with heart failure and non‐heart failure (non‐HF) controls who had cardiovascular risk factors. Both heart failure with reduced ejection fraction (HFrEF) patients and heart failure with preserved ejection fraction (HFpEF) patients were included in the study. Peptides for the Apolipoprotein AI (APOA1) protein were the most significantly differentially expressed between non‐HF and heart failure patients (P = 0.013 and P = 0.046). Four proteins were significantly differentially expressed between non‐HF and the specific subtypes of HF (HFrEF and HFpEF); Leucine‐rich‐alpha‐2‐glycoprotein (LRG1, P < 0.001), zinc‐alpha‐2‐glycoprotein (P = 0.005), serum paraoxanse/arylesterase (P = 0.013), and APOA1 (P = 0.038). A statistical model found that combined measurements of the candidate biomarkers in addition to BNP were capable of correctly predicting heart failure with 83.17% accuracy and an area under the curve (AUC) of 0.90. This was a notable improvement on predictive capacity of BNP measurements alone, which achieved 77.1% accuracy and an AUC of 0.86 (P = 0.005). The protein peptides for LRG1, which contributed most significantly to model performance, were significantly associated with future new onset HF in the non‐HF cohort [Peptide 1: odds ratio (OR) 2.345 95% confidence interval (CI) (1.456–3.775) P = 0.000; peptide 2: OR 2.264 95% CI (1.422–3.605), P = 0.001]. Conclusions: This study has highlighted a number of promising candidate biomarkers for (i) diagnosis of heart failure and subtypes of heart failure and (ii) prediction of future new onset heart failure in patients with cardiovascular risk factors. Furthermore, this study demonstrates that multiplexed measurement of a combined biomarker signature that includes BNP is a more accurate predictor of heart failure than BNP alone. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

28. Construction law.

Author

Morrissey, Brian J. and Woods, R. Kyle

Subjects
Contractors -- Laws, regulations and rules, Construction industry -- Laws, regulations and rules, Mechanics' liens -- Laws, regulations and rules
Published
1990

30. Cerebral gas embolism in a case of Influenza A-associated acute respiratory distress syndrome treated with high-frequency oscillatory ventilation

Author

Sebat, Christian, Albertson, Timothy, and Morrissey, Brian

Subjects
Air embolism -- Risk factors -- Diagnosis -- Care and treatment -- Patient outcomes -- Case studies, Respiratory distress syndrome -- Risk factors -- Diagnosis -- Care and treatment, Influenza -- Risk factors -- Diagnosis -- Care and treatment, Health
Abstract

Byline: Christian. Sebat, Timothy. Albertson, Brian. Morrissey A 22-year-old obese asthmatic woman with Influenza A (H1N1)-associated acute respiratory distress syndrome died from cerebral artery gas emboli with massive cerebral infarction [...]

Published
2013

31. OMG, where r u? c u l8r

Author

Morrissey, Brian

Subjects
Elephants -- Kenya, Elephants -- Protection and preservation, Elephants -- Observations, Proboscidea -- Kenya, Proboscidea -- Protection and preservation, Proboscidea -- Observations, Wildlife conservation -- Management, Company business management, Zoology and wildlife conservation
Published
2009

32. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).

Author

Criner, Gerard J, Sue, Richard, Wright, Shawn, Dransfield, Mark, Rivas-Perez, Hiram, Wiese, Tanya, Sciurba, Frank C, Shah, Pallav L, Wahidi, Momen M, de Oliveira, Hugo Goulart, Morrissey, Brian, Cardoso, Paulo F G, Hays, Steven, Majid, Adnan, Pastis, Nicholas Jr, Kopas, Lisa, Vollenweider, Mark, McFadden, P Michael, Machuzak, Michael, and Hsia, David W

Abstract

Rationale: This is the first multicenter randomized controlled trial to evaluate the effectiveness and safety of Zephyr Endobronchial Valve (EBV) in patients with little to no collateral ventilation out to 12 months.Objectives: To evaluate the effectiveness and safety of Zephyr EBV in heterogeneous emphysema with little to no collateral ventilation in the treated lobe.Methods: Subjects were enrolled with a 2:1 randomization (EBV/standard of care [SoC]) at 24 sites. Primary outcome at 12 months was the ΔEBV-SoC of subjects with a post-bronchodilator FEV1 improvement from baseline of greater than or equal to 15%. Secondary endpoints included absolute changes in post-bronchodilator FEV1, 6-minute-walk distance, and St. George's Respiratory Questionnaire scores.Measurements and Main Results: A total of 190 subjects (128 EBV and 62 SoC) were randomized. At 12 months, 47.7% EBV and 16.8% SoC subjects had a ΔFEV1 greater than or equal to 15% (P < 0.001). ΔEBV-SoC at 12 months was statistically and clinically significant: for FEV1, 0.106 L (P < 0.001); 6-minute-walk distance, +39.31 m (P = 0.002); and St. George's Respiratory Questionnaire, -7.05 points (P = 0.004). Significant ΔEBV-SoC were also observed in hyperinflation (residual volume, -522 ml; P < 0.001), modified Medical Research Council Dyspnea Scale (-0.8 points; P < 0.001), and the BODE (body mass index, airflow obstruction, dyspnea, and exercise capacity) index (-1.2 points). Pneumothorax was the most common serious adverse event in the treatment period (procedure to 45 d), in 34/128 (26.6%) of EBV subjects. Four deaths occurred in the EBV group during this phase, and one each in the EBV and SoC groups between 46 days and 12 months.Conclusions: Zephyr EBV provides clinically meaningful benefits in lung function, exercise tolerance, dyspnea, and quality of life out to at least 12 months, with an acceptable safety profile in patients with little or no collateral ventilation in the target lobe. Clinical trial registered with www.clinicaltrials.gov (NCT 01796392). [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

35. Screening participants' attitudes to the introduction of artificial intelligence in breast screening.

Author

de Vries, Clarisse F, Morrissey, Brian E, Duggan, Donna, Staff, Roger T, and Lip, Gerald

Subjects
*EARLY detection of cancer, *ARTIFICIAL intelligence, *CONSUMER attitudes, *LABOR demand, *MAMMOGRAMS, *HEALTH literacy, *BREAST tumors
Abstract

The article focuses on screening participants' attitudes to the introduction of artificial intelligence (AI) in breast screening and the breast cancer screening population on the use of AI in interpreting breast screening mammograms.

Published
2021
Full Text
View/download PDF

39. Do trauma systems work? A comparison of major trauma outcomes between Aberdeen Royal Infirmary and Massachusetts General Hospital.

Author

Morrissey, Brian E., Delaney, Ruth A., Johnstone, Alan J., Petrovick, Laurie, and Smith, R. Malcolm

Subjects
*HEALTH outcome assessment, *PUBLIC health, *WOUND care, *WOUNDS & injuries, *MORTALITY, *PATIENTS
Abstract

Trauma is an important matter of public health and a major cause of mortality. Since the late 1980s trauma care provision in the United Kingdom is lacking when compared to the USA. This has been attributed to a lack of organisation of trauma care leading to the formation of trauma networks and Major Trauma Centres in England and Wales. The need for similar centres in Scotland is argued currently. We assessed the activity of two quite different trauma systems by obtaining access to comparative data from two hospitals, one in the USA and the other in Scotland. Aggregate data on 5604 patients at Aberdeen Royal Infirmary (ARI) from 1993 to 2002 was obtained from the Scottish Trauma Audit Group. A comparable data set of 16,178 patients from Massachusetts General Hospital (MGH). Direct comparison of patient demographics; injury type, mechanism and Injury Severity Score (ISS); mode of arrival; length of stay and mortality were made. Statistical analysis was carried out using Chi-squared and Cochran–Mantel–Haenszel. There were significant differences in the data sets. There was a higher proportion of penetrating injuries at MGH, (8.6% vs 2.6%) and more severely injured patients at MGH, patients with an ISS > 16 accounted for nearly 22.1% of MGH patients compared to 14.0% at ARI. ISS 8–15 made up 54.6% of ARI trauma with 29.6% at MGH. Falls accounted for 50.1% at ARI and 37.9% at MGH. Despite the higher proportion of severe injuries at MGH and crude mortality rates showing no difference (4.9% ARI vs 5.2% MGH), pooled odds ratio of mortality was 1.4 (95% confidence interval 1.2–1.6) showing worse mortality outcomes at ARI compared to MGH. In conclusion, there were some differences in case mix between both data sets making direct comparison of the outcomes difficult, but the effect of consolidating major trauma on the proportion and number of severely injured patients treated in the American Level 1 centre was clear with a significant improvement in mortality in all injury severity groups. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

41. Occupational Asthma.

Author

Kenyon, Nicholas, Morrissey, Brian, Schivo, Michael, and Albertson, Timothy

Abstract

Occupational asthma is the most common occupational lung disease. Work-aggravated asthma and occupational asthma are two forms of asthma causally related to the workplace, while reactive airways dysfunction syndrome is a separate entity and a subtype of occupational asthma. The diagnosis of occupational asthma is most often made on clinical grounds. The gold standard test, specific inhalation challenge, is rarely used. Low molecular weight isocyanates are the most common compounds that cause occupational asthma. Workers with occupational asthma secondary to low molecular weight agents may not have elevated specific IgE levels. The mechanisms of occupational asthma associated with these compounds are partially described. Not all patients with occupational asthma will improve after removal from the workplace. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

42. The Critically Ill Asthmatic-from ICU to Discharge.

Author

Louie, Samuel, Morrissey, Brian, Kenyon, Nicholas, Albertson, Timothy, and Avdalovic, Mark

Abstract

Status asthmaticus (SA) is defined as an acute, severe asthma exacerbation that does not respond readily to initial intensive therapy, while near-fatal asthma (NFA) refers loosely to a status asthmaticus attack that progresses to respiratory failure. The in-hospital mortality rate for all asthmatics is between 1% to 5%, but for critically ill asthmatics that require intubation the mortality rate is between 10% to 25% primarily from anoxia and cardiopulmonary arrest. Timely evaluation and treatment in the clinic, emergency room, or ultimately the intensive care unit (ICU) can prevent the morbidity and mortality associated with respiratory failure. Fatal asthma occurs from cardiopulmonary arrest, cerebral anoxia, or a complication of treatments, e.g., barotraumas, and ventilator-associated pneumonia. Mortality is highest in African-Americans, Puerto Rican-Americans, Cuban-Americans, women, and persons aged ≥ 65 years. Critical care physicians or intensivists must be skilled in managing the critically ill asthmatics with respiratory failure and knowledgeable about the few but potentially serious complications associated with mechanical ventilation. Bronchodilator and anti-inflammatory medications remain the standard therapies for managing SA and NFA patients in the ICU. NFA patients on mechanical ventilation require modes that allow for prolonged expiratory time and reverse the dynamic hyperinflation associated with the attack. Several adjuncts to mechanical ventilation, including heliox, general anesthesia, and extra-corporeal carbon dioxide removal, can be used as life-saving measures in extreme cases. Coordination of discharge and follow-up care can safely reduce the length of hospital stay and prevent future attacks of status asthmaticus. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

43. Are Fluoroquinolones Superior Antibiotics for the Treatment of Community-Acquired Pneumonia?

Author

Albertson, Timothy, Morrissey, Brian, and Chan, Andrew

Abstract

Various guidelines for the antibiotic treatment of community-acquired pneumonia (CAP) are presented that include fluoroquinolone antibiotics. The efficacy of current fluoroquinolone antibiotics in the treatment of CAP is summarized. Healthcare resource utilization and shortened duration of clinical symptoms have been shown in some, but not all of CAP trials utilizing fluoroquinolone antibiotics. Although evidence for both the clinical and microbiological efficacy of fluoroquinolone antibiotics is abundant, no convincing data demonstrates that they are superior to other standard antibiotics included in CAP guidelines. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

44. Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.

Author

Vasu, Vihas T., de Cruz, Sharon J., Houghton, Jessica S., Hayakawa, Keri A., Morrissey, Brian M., Cross, Carroll E., and Eiserich, Jason P.

Subjects
THIOLS, ANTIOXIDANTS, CYSTIC fibrosis, SPUTUM, PEROXIDASE, CHLORAMINES, GLUTATHIONE
Abstract

Neutrophil-dependent reactions catalysed by myeloperoxidase (MPO) are thought to play important roles in the pulmonary pathobiology of cystic fibrosis (CF). Aerosolized thiol antioxidants such as glutathione (GSH) and N-acetylcysteine (NAC) are currently being utilized as therapeutics to modify CF respiratory tract oxidative processes. This study hypothesized that MPO in CF airway lining fluids may be a target of such therapeutics. MPO activity in sputum from 21 adult CF patients was found to be inversely associated with lung function (FEV1). In contrast, systemic inflammation (assessed by plasma C-reactive protein) was not correlated with lung function. Ex vivo studies revealed that GSH and NAC effectively scavenged N-chloramines in sputum and inhibited sputum MPO activity with potency exquisitely dependent upon MPO activity levels. Detailed kinetic analyses revealed that NAC and GSH inhibit MPO by distinct mechanisms. Activation of the key pro-inflammatory transcription factor NF-κB in cultured HBE1 cells was inhibited by GSH. The findings reveal that MPO activity and its reactive products represent useful predictors of the doses of inhaled thiol antioxidants required to ameliorate airway oxidative stress and inflammation in CF patients and provide mechanistic insight into the antioxidative/anti-inflammatory mechanisms of action of GSH and NAC when administered into the CF lung. [ABSTRACT FROM AUTHOR]

Published
2011
Full Text
View/download PDF

45. Medium-mediated effects increase cell killing in a human keratinocyte cell line exposed to solar-simulated radiation.

Author

Maguire, Alanna, Morrissey, Brian, Walsh, James E., and Lyng, Fiona M.

Subjects
*CELL death, *SOLAR radiation simulation, *PHYSIOLOGICAL effects of solar radiation, *KERATINOCYTES, *CELL culture, *VITAMIN B2, *PHOTOSENSITIZERS, *ACTIVE oxygen in the body
Abstract

Purpose: The objective of this study was to investigate whether cell culture medium is a biologically relevant exposure medium that can be employed in non-ionising photobiological investigations. Methods: The effect of solar-simulated irradiation on cell culture medium and its ability to elicit cell death was studied. The role of reactive oxygen species (ROS), cell secreted factors, and the contribution of individual components of the medium were investigated. Results: Cell death was found to be primarily mediated through the formation of ROS via riboflavin photosensitisation and degradation in the cell culture medium. Phenol red was found to significantly reduce the cell killing ability of riboflavin. Exposures in riboflavin-free medium resulted in significantly increased cell survival compared to identical exposures in riboflavin containing medium. Conclusions: This study has shown that solar radiation toxicity is augmented by cell culture medium due to the presence of riboflavin. Results suggest that exposures performed in phenol red-free medium may serve to increase phototoxic effects if riboflavin is present. Riboflavin-free media is recommended for solar radiation investigations to eliminate concerns regarding riboflavin photosensitisation and nutrient deprivation. [ABSTRACT FROM AUTHOR]

Published
2011
Full Text
View/download PDF

46. Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway

Author

Chapman, Anna L.P., Morrissey, Brian M., Vasu, Vihas T., Juarez, Maya M., Houghton, Jessica S., Li, Chin-Shang, Cross, Carroll E., and Eiserich, Jason P.

Subjects
*CYSTIC fibrosis, *EPITHELIUM, *PHAGOCYTES, *HEMOPROTEINS, *REACTIVE oxygen species, *PEROXIDASE, *OXIDATIVE stress, *METABOLISM, *PATIENTS
Abstract

Abstract: Background: Decreased expired nitric oxide (eNO) is commonly observed in cystic fibrosis (CF) patients and is usually explained by dysregulation of NO synthase (NOS) isoforms in respiratory tract epithelium. Later stages of this disease are accompanied by intense airway infiltration of phagocytes with high NOS activity, abundant levels of the hemoprotein myeloperoxidase (MPO) and significant production of significant reactive oxygen species. Methods: This study characterizes the contribution of the high airway levels of MPO to decreased eNO levels in adult CF patients. NO metabolites (NO x ) and MPO levels in fresh sputum of control and adult CF patients were determined and related to measurements of eNO and to in vitro consumption of NO in CF sputum. Results: Despite essentially equal levels of NO x in sputum, eNO was 2- to 3-fold lower in CF patients compared to healthy controls. In CF patients, eNO levels were negatively associated with sputum peroxidase activity. In vivo correlations were confirmed by ex vivo studies of NO consumption by MPO in CF sputum. Immunodepletion studies confirmed MPO as the major heme peroxidase in CF sputum contributing to the hydrogen peroxide (H2O2)-dependent consumption of NO. Conclusions: In CF airways MPO acts as a phagocyte-derived NO oxidase that diminishes NO bioavailability at airway surfaces, possibly identifying this peroxidase as a potential target for therapeutic intervention. [Copyright &y& Elsevier]

Published
2010
Full Text
View/download PDF

47. The technique of adult flexible bronchoscopy: Part 1.

Author

Yoneda, Ken Y. and Morrissey, Brian M..

Abstract

The article reports on the technique of adult flexible bronchoscopy. It mentions that the method was introduced in 1968 by Shigeto Iketa and is used for therapy and diagnosis. The new bronchoscopes provide high-resolution images and are more cost-effective and efficient. The article describes the transmission of images in types of bronchoscopes.

Published
2008

48. Pharmaceutical Manufacturers’ Response to COVID-19.

Author

Gerberding, Julie, Morrissey, Brian, and Dozier, Eric

Subjects
*COVID-19, *SEMINOMA
Abstract

The article discusses the drug manufacturers' response to the COVID-19 pandemic and mentions a recent collaboration in the fight against the novel coronavirus.

Published
2020

49. Suppression of Leukotriene B 4 Generation by Ex-vivo Neutrophils Isolated from Asthma Patients on Dietary Supplementation with Gammalinolenic Acid-containing Borage Oil: Possible Implication in Asthma.

Author

Ziboh, Vincent A., Naguwa, Stanley, Vang, Kao, Wineinger, Julie, Morrissey, Brian M., Watnik, Mitchell, and Gershwin, M. Eric

Subjects
LEUKOTRIENES, NEUTROPHILS, ASTHMATICS, ASTHMA, BORAGE, CORN oil
Abstract

Dietary gammalinolenic acid (GLA), a potent inhibitor of 5-lipoxygenase (5-LOX) and suppressor of leukotriene B 4 (LTB 4 ), can attenuate the clinical course of rheumatoid arthritics, with negligible side effects. Since Zileuton, also an inhibitor of 5-LOX, attenuates asthma but with an undesirable side effect, we investigated whether dietary GLA would suppress biosynthesis of PMN-LTB 4 isolated from asthma patients and attenuate asthma. Twenty-four mild-moderate asthma patients (16-75 years) were randomized to receive either 2.0 g daily GLA (borage oil) or corn oil (placebo) for 12 months. Blood drawn at 3 months intervals was used to prepare sera for fatty acid analysis, PMNs for determining phospholipid fatty acids and for LTB 4 generation. Patients were monitored by daily asthma scores, pulmonary function, and exhaled NO. Ingestion of daily GLA (i) increased DGLA (GLA metabolite) in PMN-phospholipids; (ii) increased generation of PMN-15-HETrE (5-LOX metabolite of DGLA). Increased PMN-DGLA/15-HETrE paralleled the decreased PMN generation of proinflammatory LTB 4 . However, the suppression of PMN-LTB4 did not reveal statistically significant suppression of the asthma scores evaluated. Nonetheless, the study demonstrated dietary fatty acid modulation of endogenous inflammatory mediators without side effects and thus warrant further explorations into the roles of GLA at higher doses, leukotrienes and asthma. [ABSTRACT FROM AUTHOR]

Published
2004
Full Text
View/download PDF

50. Nitric oxide and protein nitration in the cystic fibrosis airway

Author

Morrissey, Brian M., Schilling, Kevin, Weil, John V., Silkoff, Philip E., and Rodman, David M.

Subjects
*CYSTIC fibrosis, *RESPIRATORY insufficiency, *NITRIC oxide
Abstract

Cystic fibrosis (CF), characterized by chronic airway infection and inflammation, ultimately leads to respiratory failure. Exhaled nitric oxide (NO), elevated in most inflammatory airway diseases, is decreased in CF, suggesting either decreased production or accelerated metabolism of NO. The present studies performed on two groups of CF patients provide further support for a disordered NO airway metabolism in CF respiratory tract disease. Despite confirmation of subnormal NOS2 in the CF airway epithelium, alternative isoforms NOS1 and NOS3 were present, and inflammatory cells in the CF airway expressed abundant NOS2. Increased immunohistochemical staining for nitrotyrosine was demonstrated in lung tissues from patients with CF as compared to control. To our knowledge, this is the first report localizing nitrotyrosine in diseased CF lung tissue. While the relative NOS2 deficiency in CF respiratory tract epithelium may contribute to the lower expired NO levels, these results suggest that increased metabolism of NO is also present in advanced CF lung disease. The significance of altered NO metabolism and protein nitration in CF remains to be fully elucidated. [Copyright &y& Elsevier]

Published
2002
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results